Comparison of three high-resolution digitizers for radiochromic film dosimetry

A recently introduced radiographic film scanner from Howtek is evaluated and compared to two other commercially available densitometry systems for its use in radiochromic (RC) film dosimetry in the clinical dose range 0-100 Gy. It has a high-intensity red LED light-source centered at 662 nm (near the major absorption peak for RC film), and is coupled to a CCD linear array detector. This new densitometry system is directly compared to two high-resolution film scanners commonly employed in RC film dosimetry, namely the Lumiscan 75 digitizer (He-Ne laser light source) and the Vidar VXR-16 digitizer (fluorescent light source). A spot densitometer (Nuclear Associates Radiochromic Densitometer) with a filtered 671 nm laser-diode light source is also included as a reference for comparison. The response of the spot densitometer and three high-resolution digitizers is characterized by the dose required to reach a net optical density of 1 (DNOD1), and is 16.0, 37.3, and 46.4 Gy for the Nuclear Associates Radiochromic Densitometer, Howtek MultiRAD 460 and Lumiscan 75 digitizer, respectively. The Vidar VXR-16 does not reach a net optical density of 1. The minimum usable dose at which a 2% level of uncertainty can be achieved (MUD2%) on the three digitizers are 2.6, 6.0, and 38.5 Gy for the Howtek MultiRAD 460, Lumiscan 75, and Vidar VXR-16, respectively. The Howtek MultiRAD 460 shows the greatest sensitivity, lowest MUD2% and best signal-to-noise ratio in the clinical dose range 0-100 Gy. Furthermore, it has no apparent interference (moiré) artifacts that severely limit the low optical density region of the He-Ne laser digitizer. For high-resolution radiochromic dosimetry in the clinical dose range 0-100 Gy, the high-intensity red LED light-source digitizer proves to be the superior modality.

A new geometric and mechanical verification device for medical LINACs

The goal of quality assurance (QA) for a radiation oncology medical LINAC is to maintain an acceptable level of equipment performance and reliability. The increasing complexity of Radiation Oncology equipment and treatment techniques have led to increased demands on the work load of the medical physicist. Regular testing needs to be as efficient as possible. Generally, the QA tests, as recommended by the AAPM Task Group 40 for medical LINACs, can be grouped into two categories: dosimetry and mechanical checks. A new QA device has been developed that facilitates many of the daily and monthly mechanical QA checks. Its efficiency and speed is achieved through a set of QA tools that are mounted on a single platform, which is designed to fit into the accessory mount of the medical LINAC. Named Mini-GARD (MG), it verifies the accuracy of the digital readouts for gantry angles, collimator angles, and field sizes. It also tests crosshair position, the optical distance indicator (ODI), and patient setup laser alignment. It uses two calibrated digital levels for the gantry and collimator angle verification, an electronic tape measure for ODI verification, and a calibrated transparent projection scale for the remaining tests. This paper evaluates the stability and accuracy of the device in clinical tests over a period of a year. Results show that the MG is reliable and capable of measuring gantry and collimator angle constancy to +/-0.3 degrees, ODI constancy to +/-0.05 cm, and field size accuracies to +/-0.05 cm.

The use of an inexpensive red acetate filter to improve the sensitivity of GAFChromic dosimetry

The sensitivity of GAFChromic dosimetry using a conventional broad band light source densitometer has significantly been improved twofold using an inexpensive red acetate filter overlay during the densitometric measurements. This thin sheet of red acetate enhances the dosimetric analysis of radiochromic blue image distributions recorded on GAFChromic films. The combination provides higher sensitivity in the optical density measurements than the more expensive He-Ne laser-scanning densitometers.

The thermal characteristics of different diodes on in vivo patient dosimetry

Diode sensitivity variations with temperature (SVWT) have been reported to vary from small negative values up to 0.6% per degrees C. Thus it is possible for diode calibration factors established at room temperature (approximately 20 degrees C) to yield errors in the range of -1% to +9% when diodes are placed on a patient's skin (approximately 30 degrees C) for in vivo entrance dose measurements. In this study we simulated several skin temperatures using a temperature-controlled aluminum surface in contact with a section of Bolus. The internal temperatures of several diodes with different buildup thickness were monitored as a function of time when placed in contact with the heated bolus. Our results indicate that for different combinations of room temperature (18 degrees C-23 degrees C) and patient skin temperature (28 degrees C-34 degrees C) diodes reached 90% of their equilibrium temperature within 3-5 min. In addition, the range of typical skin temperatures was determined by measurements performed on a number of actual patients under clinical conditions. Based on the results of our experiments a protocol was developed to minimize the temperature based errors for in vivo dosimetry.

Evaluation of an innovative plastic cube phantom designed to improve the efficiency of accelerator QA

A new cubic phantom was designed to improve the efficiency on the QA measurement of accelerator. It has a variety of applications, such as dose constancy check, depth dose verifications, and symmetry and flatness evaluations. In particular, this new design makes it much easier to perform the check on output constancy vs. gantry angles as a cylindrical ion chamber positioned at the center of the phantom. The reproducibility of the setup using this phantom has been investigated. The charge effect of the phantom is found to be insignificant. It also reduces the monthly dosimetric QA time spent on a typical multimodality accelerator by approximately 40%.

Calculation of dose distribution near an innovative concentric balloon catheter for endovascular brachytherapy

PURPOSE

Using a radioactive solution-filled catheter for intravascular irradiation has the potential problem of chemical and radiological toxicity in the case of a balloon rupture. In order to reduce this risk, an innovative concentric balloon catheter was developed.

METHODS AND MATERIALS

The concentric balloon was made by inner and outer balloons filled with saline and radioactive solution, respectively. The optimal inner radius was determined by comparing the dose rate reduction vs. the volume reduction for various inner and outer radii for 188Re, 32P, and 90Y solutions.

RESULTS

For a balloon with an outer radius of 1.5 mm, there was no advantage of a concentric balloon. For balloons with outer radii of 3.0 and 5 mm, the optimal inner radius was 1.5 and 3 mm, respectively.

CONCLUSIONS

With the newly designed concentric balloon, the risk of toxicity can be reduced while keeping the dose rate high enough so that the treatment times within tolerable limits are still maintained.

A new genetic algorithm technique in optimization of permanent 125I prostate implants

Real time optimized treatment planning at the time of the implant is desirable for ultrasound-guided transperineal 125I permanent prostate implants. Currently available optimization algorithms are too slow to be used in the operating room. The goal of this work is to develop a robust optimization algorithm, which is suitable for such application. Three different genetic algorithms (sGA, sureGA and securGA) were developed and compared in terms of the number of function evaluations and the corresponding fitness. The optimized dose distribution was achieved by searching the best seed distribution through the minimization of a cost function. The cost function included constraints on the periphery dose of the planned target volume, the dose uniformity within the target volume, and the dose to the critical structure. Adjustment between the peripheral dose, the dose uniformity and critical structure dose can be achieved by varying the weighting factors in the cost function. All plans were evaluated in terms of the dose nonuniformity ratio, the conformation number and the dose volume histograms. Among these three GA algorithms, the securGA provided the best performance. Within 2500 function evaluations, the near optimum results were obtained. For a large target volume (5 cm x 4 cm x 4.5 cm) including urethra with 20 needles, the computer time needed for the optimization was less than 5 min on a HP735 workstation. The results showed that once the best set of parameters was found, they were applicable for all sizes of prostate volume. For a fixed needle geometry, the optimized plan showed much better dose distribution than that of nonoptimized plan. If the critical structure was considered in the optimization, the dose to the critical structure could be minimized. In the cases of irregular and skewed needle geometry, the optimized treatment plans were almost as good as ideal needle geometry. It is concluded that this new genetic algorithm (securGA) allows for an efficient and rapid optimization of dose distribution, which is suitable for real time treatment planning optimization for ultrasound-guided prostate implant.

A rapid colour stabilization technique for radiochromic film dosimetry

Various forms of GAFChromic film have been used for several years as radiographic media for measuring dose distributions of brachytherapy sources and small radiation fields. Upon irradiation the film changes colour and darkens with time post-irradiation. The darkening is most rapid in the first 24 h, and it has been suggested that for accurate dosimetry a waiting period of 24 h should occur before any optical density (OD) measurements are taken. A more rapid colour stabilization (RCS) procedure has been developed and is evaluated. The procedure consists of heating the film post-irradiation for a period of 2 h at 45 degrees C. The RCS procedure is compared with a control group and the dose response is tested for linearity, stability and reproducibility using two densitometers with light sources at different wavelengths (632.8 nm and 671 nm). The rise in net optical density (NOD) for the period 3-168 h is less than 3% for the RCS group as compared with 12% for the controls. In the first 24 h, the increase in NOD for the RCS samples is less than 0.5%, as opposed to 6% for the control group.

The use of improved radiochromic film for in vivo quality assurance of high dose rate brachytherapy

GAFChromic film has become increasingly popular for radiation dosimetry. In this study we explore the use of GAFChromic film as an in vivo dosimeter for quality assurance (QA) of fractionated high dose rate 192Ir treatments. Accuracy of dose distribution is explored for the simple vaginal cylinder geometry for which the dose can be easily calculated for comparison. Source dwell times for several patients were optimized to deliver 500 cGy at 0.5 cm from the surface of the vaginal cylinder applicator using a commercial treatment planning system. GAFChromic film was taped to the vaginal cylinder applicator and was enclosed in a leak proof rubber sleeve prior to its insertion. Optical densities were measured along the film at 2 mm spacing, using a densitometer with filtered red light. Density corrections for transient film darkening effects were made and optical densities were converted to absorbed dose in cGy. In vivo patient dose distribution measured for different patients and different fractions were compared with the calculated values along the applicator surface. The variation between the calculated and measured dose was +/- 10%. the reproducibility of dose measurement for different fraction was within +/- 5%. This study demonstrates the potential usefulness of the film as an in vivo for brachytherapy QA.

Evaluation of a new sealed reentrant well chamber for HDR and LDR brachytherapy calibrations

A new reentrant ionization chamber SNC 1008 has been introduced for low dose rate (LDR) and high dose rate (HDR) brachytherapy source calibrations. There is no air density correction requirement for the chamber since it is hermetically sealed. In this study we evaluate its use for HDR as well as LDR source calibrations. The magnitude of the ionization current collected was found to be independent of the sign of the polarizing voltage within +/- 0.5%. The axial response curve of the well chamber reveals a "plateau region" (+/- 0.5% dose variation) of 4.2 cm, which is larger than the published values for other commercially available chambers. Long-term stability of the chamber was evaluated. Short-term response and source positioning reproducibility were tested using both LDR and HDR sources. Ion collection efficiency was found to be high, making the chamber suitable for HDR 192Ir sources.

A feasibility study of automated inverse treatment planning for cancer of the prostate

PURPOSE

The development of automated "inverse planning," utilizing intensity-modulated radiation therapy (IMRT) raises the question of whether this new technique can provide a practical and efficient means of dose escalation in conformal treatment of cancer of the prostate. The purpose of this feasibility study was to determine a single set of inverse-planning parameters that can be used for a variety of different prostate patient geometries to automatically generate escalated dose (> or = 81 Gy) IMRT plans that satisfy normal tissue constraints for rectal and bladder walls.

METHODS

We studied a subset of the 46 patients who were previously treated at Memorial Sloan Kettering Cancer Center (MSKCC) to a total dose of 81 Gy using a 3D conformal approach. Six patients were selected for our study and replanned using an analytical inverse-planning algorithm (referred to as OPT3D) applied to 8 intensity modulated, co-axial radiation beams. A set of more than a dozen inverse planning parameters were adjusted by trial and error until the resulting dose distributions satisfied the critical organ dose-volume constraints imposed by our study rules (D30 < or = 75.6 Gy and D10 < or = 80 Gy for the rectal wall; D15 < or = 80 Gy for the bladder wall) for the sample of patients selected. The OPT3D-generated plans were compared to hand-generated BEV plans using cumulative DVH analysis.

RESULTS

A single set of inverse-planning parameters was found that was able to automatically generate IMRT plans meeting all critical organ dose-volume constraints for all but one of the patients in our study. [The exception failed to meet bladder dose constraints for both IMRT and BEV methods, due to extensive overlap between the planning target volume (PTV) and bladder contours]. Based upon analysis of the cumulative dose-volume histogram (DVH) for the prostate PTV, the D95 (DX is defined such that x% of the volume receives a dose > or = DX), averaged over all patients, was approximately 81 Gy. The average D90 and mean dose values were 85 Gy and 93 Gy, respectively. Although a similar D95 was achieved using the BEV-generated plans, the D90 and mean dose values were substantially higher for the inverse planning (OPT3D) method.

CONCLUSION

This limited "paper study" shows IMRT with inverse planning to be a promising technique for the treatment of prostate cancer to high doses. We determined a small set of inverse-planning parameter values that was able to automatically design intensity-modulated radiotherapy (IMRT) plans for a subset of 6 patients previously treated at MSKCC to 81 Gy using BEV planning techniques. With one minor exception, the resulting plans succeeded in meeting predetermined dose-volume constraints while at the same time allowing an increase in the mean dose and D90 to the prostate PTV. These 8 field plans also resulted in reduced dosage to the femoral heads. This automated technique is efficient in terms of planning effort and, with proper software for computer-controlled MLC, may be appropriate for clinical use. The clinical feasibility of this approach for a larger group of patients is currently under study.

Predicting optical densitometer response as a function of light source characteristics for radiochromic film dosimetry

Various forms of GAFChromic (GC) film have been used for several years as radiographic media for measuring dose distributions of brachytherapy sources and small radiation fields. In order to optimize the measurement sensitivity and thus improve precision, we describe a method to calculate the dose response curves (net optical density at a give wavelength or spectrum versus absorbed dose) for different densitometer light sources using measured GC film absorption spectra. Comparison with measurements on the latest version of GC film (model MD-55-2) using four types of densitometers [He-Ne laser, broadband (white light) densitometer, and two LED (red-light) filtered densitometers] confirm the accuracy of this predictive model. The linearity and sensitivity of the dose response curves are found to be highly dependent on the light source spectrum. Initial slope is a function of the average weighted absorbance. Early saturation and decreased linearity of the dose response curves are ascribed to the nonuniform transmission of the light source through the GC film. We found that an LED (red-light) source with a narrow bandpass filter centered at 671 nm near the major absorption peak achieves nearly the maximum possible sensitivity (almost four times more sensitive than He-Ne laser, 632.8 nm) and may be suitable for in vivo dosimetry.

The investigation of 32P wire for catheter-based endovascular irradiation

The dose distribution from a 32P source has been measured and calculated in order to evaluate its application in endovascular irradiation. The source dimension was 27 mm in length and 0.3 mm in diameter and was embedded in the end of a Ni-Ti wire. Dose measurements were performed using radiochromic film in several specially designed tissue equivalent phantoms. Loevinger's point dose kernel was used for the calculation. The approximate dose rate at a radial distance of 1.5 mm from the center of the source was found to be 6.75 cGy/s per GBq (0.25 cGy/s per mCi), which allows the delivery of a therapeutic dose in a short time interval with a satisfactory homogeneity without stepping the source. However, the dose rate falls off almost exponentially along the radial distance. Therefore it may not be suitable for treating large diameter vessel from a centrally located source. The effect of a curved 32P wire source on the radial dose distribution was also investigated. The results showed that for a maximum bend of 180 degrees the dose rate was increased by as much as 20% along the inner radial distance but decreased by as much as 20% along the outer radial distance compared to the dose along a straight wire. However, for curvatures normally encountered in a clinical situation, the dose rate was changed less than 5%.

Comparison of dose response of radiochromic film measured with He-Ne laser, broadband, and filtered light densitometers

Dose response curves for GAFChromic MD-55-2 film were measured using three different densitometer systems: a He-Ne laser densitometer, a broadband (white light) densitometer, and a filtered red light densitometer. These were found to differ significantly; the dose needed to achieve a net optical density of 1 (DNOD1) was greater than 100 Gy for the white light densitometer, 56 Gy for the He-Ne densitometer, and only 14.8 Gy for the filtered red light densitometer. This represents approximately a fourfold increase in response for the filtered red light versus the He-Ne laser densitometer, which is a significant improvement. For some patient prescriptions this enables us to achieve an accuracy and precision sufficient to verify daily dose to within 5%.

Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries

PURPOSE

Recent data indicate that intraluminal irradiation of coronary arteries following balloon angioplasty reduces proliferation of smooth muscle cells, neointima formation, and restenosis. We present calculations for various isotopes and geometries in an attempt to identify suitable source designs for such treatments.

METHODS AND MATERIALS

Analytical calculations of dose distributions and dose rates are presented for 192Ir, 125I, 103Pd, 32P, and 90Sr for use in intracoronary irradiation. The effects of source geometry and positioning accuracy are studied.

RESULTS

Accurate source centering, high dose rate, well-defined treatment volume, and radiation safety are all of concern; 15-20 Gy are required to a length of 2-3 cm of vessel wall (2-4 mm diameter). Dose must be confined to the region of the angioplasty, with reduced doses to normal tissues. Beta emitters have radiation safety advantages, but may not have suitable ranges for treating large diameter vessels. Gamma emitters deliver larger doses to normal tissues and to staff. Low energy x-ray emitters such as 125I and 103Pd reduce these risks but are not available at high enough activities. The feasibility of injecting a radioactive liquid directly into the angioplasty balloon is also explored.

CONCLUSIONS

Accurate source centering is found to be of great importance. If this can be accomplished, then high energy beta emitters such as 90Sr would be ideal sources. Otherwise, gamma emitters such as 192Ir may be optimal. A liquid beta source would have optimal geometry and dose distribution, but available sources, such as 32P are unsafe for use with available balloon catheters.

Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia

Recent reports suggest that intraluminal irradiation of coronary arteries in conjunction with balloon angioplasty reduces proliferation of smooth muscle cells and neointima formation, thereby inhibiting restenosis. One possible irradiation technique is to inflate the balloon dilitation catheter with a radioactive solution. This has advantages over other proposed irradiation procedures, in that accurate source positioning and uniform dose to the vessel wall are assured. Several high-energy beta-minus emitters may be suitable for this application. We present experimental measurements and analytical calculations of the dose distribution around a 3-mm-diam by 20-mm-long balloon filled with 90Y-chloride solution. The dose rate at the surface of the balloon is approximately 0.14 cGy/s per mCi/ml (3.78 x 10(-11) Gy/s per Bq/ml), with the dose decreasing to 53% at 0.5 mm, and < 5% at 3.5-mm radial distance. 90Y and other possible isotopes are currently available at specific concentrations > or = 50 mCi/ml (1.85 x 10(9) Bq/ml), which enables the delivery of 20 Gy in less than 5 min. The dosimetric and radiation safety advantages of this system warrant further feasibility studies. Issues of concern include incorporating the beta-emitter into a suitable chemical form, and assessing organ and whole body doses in the (< 1 in 10(3)) event of balloon failure.

Investigation of a phase-only correlation technique for anatomical alignment of portal images in radiation therapy

A new image registration algorithm based on phase-only correlation is applied to portal images in radiation therapy to detect translational shift. The phase-only correlation shows a sharp peak in the correlation distribution as compared to the broad peak computed from conventional correlation using fast Fourier transform. In this paper, the algorithm of phase-only correlation is described and its applicability and robustness are tested when applied to portal images used in clinical radiation oncology. The results achieved give evidence that the phase-only correlation will deliver an alternative approach for image registration and image comparison, that may be applicable in routine clinical practice.

A new isocenter shift method for ideal geometric matching of two adjacent fields

The most commonly used technique for matching two adjoining parallel opposed fields has been geometric matching with a skin gap calculation. Many modifications have been suggested in order to minimize the shortcomings of this technique. Most of these, however, are more complex and time consuming in clinical practice, with little dosimetric improvement. We propose a simple new method for adjacent field abutment that eliminates hot and cold spots due to different beam divergences. This method is based upon the use of a single match plane for both the cephalad and caudad parallel opposed beams. The divergence angle of these opposed beams is forced to be equal at the junction through the use of the same field length and the same target axis distance (TAD). For the isocentric treatment case, the procedure is summarized as follows. After setting up the cephalad AP/PA fields to midplane in the conventional manner, the patient support couch is shifted longitudinally in the cephalad direction by a precise distance equal to the cephalad field length. The superior collimator of the caudad field is kept the same as for the cephalad field to ensure equal divergence angles. The actual irradiated volume of the caudad field is adjusted as needed by a large block or an asymmetric jaw. An analogous procedure is described for the nonisocentric case. This new isocenter shift method culminates in several distinct advantages over the other geometric methods.(ABSTRACT TRUNCATED AT 250 WORDS)

Monitor unit calculation for large wedged high-energy photon beams

With the modern high-energy linear accelerators, the following beam characteristics have to be taken into account in the monitor unit (MU) calculation of a wedged treatment: (i) the field size dependence of wedge factors; (ii) the changes in depth dose and maximum build-up depth (dmax) induced by wedges; and (iii) the field size dependence of dmax. The incorporation of a field size specific wedge factor in an MU calculation is straightforward. Effects (ii) and (iii) however, often cause confusion and inconsistency in the choices of the reference depth for wedge factors and the normalization depth for wedged depth dose, and consequently can lead to inconsistent MU calculation formalism with additional efforts of up to 7% in the delivered dose. In this note, we illustrate a derivation of an exact central axis MU calculation for wedged treatments, which correctly accounts for the effects mentioned above.

Energy response of agar-alanine free radical dosimetry to therapeutic electron beams

Calculations of the energy response of an agar-alanine phantom dosimeter (AAPD) to electrons in the energy range of 0.15-20 MeV together with experimental results at 16 MeV are presented. It is shown that the sensitivity of the EPR dosimeter (EPR signal/Gray) is independent of alanine crystal size and varies less than 2%, in the electron energy range indicated. Thus, the measured free radical density distribution may be used directly as an indication of the absorbed dose distribution in an irradiated phantom.

Microdosimetry for boron neutron capture therapy

Preclinical studies for boron neutron capture therapy (BNCT) using epithermal neutrons are ongoing at several laboratories. The absorbed dose in tumor cells is a function of the thermal neutron flux at depth, the microscopic boron concentration, and the size of the cell. Dosimetry is therefore complicated by the admixture of thermal, epithermal, and fast neutrons, plus gamma rays, and the array of secondary high-linear-energy-transfer particles produced within the patient from neutron interactions. Microdosimetry can be a viable technique for determining absorbed dose and radiation quality. A 2.5-cm-diameter tissue-equivalent gas proportional counter has been built with 50 parts per million (ppm) 10B incorporated into the walls and counting gas to simulate the boron uptake anticipated in tumors. Measurements of lineal energy (y) spectra for BNCT in simulated volumes of 1-10 microns diameter show a dose enhancement factor of 4.3 for 30 ppm boron, and a "y" of 250 keV/microns for the boron capture process. Chamber design plus details of experimental and calculated linear energy spectra will be presented.

Assessment of geometric treatment accuracy using time-lapse display of electronic portal images

During the past two years, several electronic portal imaging systems have been introduced to the market by therapy accelerator manufacturers and other vendors. While these systems differ substantially in their detection technology, they are all capable of displaying portal images on a video screen in near real-time, and of creating multiple static (or "movie") images during each treatment. Major questions confront the users of such systems as to the best utilization of this wealth of information, and to its value in comparison to traditional weekly portal film methods. Using an "in-house" video based system, a new technique was established to aid in the assessment of on-line images so that immediate "go/no-go" decisions can be made by the therapy technologist. A video "movie-loop" is displayed which consists of the static image of the initial (approved) set-up, and the current treatment image. Multiple images of successive treatments can also be viewed in this "time-lapse" display mode to provide a quick visual means for review of an entire course of therapy. The on-line imaging system hardware is composed of a combination copper-plate/fluorescent-screen detector, a front surface mirror angled at 45 degrees to remove the camera from the direct radiation beam, and a high sensitivity SIT video camera. This assembly is attached to a rigid base and mounted directly to the isocentric gantry. The geometry is fixed to within +/- 1 mm and assures the precise day-to-day reproducibility which is necessary for the success of the time-lapse display technique. Experience with this technique shows it to enhance the user's ability to notice small changes in patient's position with respect to the radiation field. Radiation treatment sites reviewed using this procedure were Hodgkin's (mantle), Lung, Brain and extremities. Shifts in patient position on the order of several millimeters were readily detectable, as will be demonstrated in this paper. Somewhat surprisingly, grosser movements (greater than 1 cm) were also noted despite overall technical excellence as assessed by weekly portal filming. The eye senses day-to-day movement with greater ease when the fields are seen in time-lapse display than when compared as discrete portal images. Ultimately, persistent movement appreciated on the time-lapse display can suggest the need for a change in patient set-up or immobilization technique.

A review of electronic portal imaging devices (EPIDs)

On-line electronic portal imaging devices are beginning to come into clinical service in support of radiotherapy. A variety of technologies are being explored to provide real-time or near real-time images of patient anatomy within x-ray fields during treatment on linear accelerators. The availability of these devices makes it feasible to verify treatment portals with much greater frequency and clarity than with film. This article reviews the physics of high-energy imaging and describes the operation principles of the electronic portal imaging devices that are under development or are beginning to be used clinically.

Tests of an electron monitor for routine quality control measurements of electron energies

The depth dose for electrons is sensitive to energy and the AAPM Task Group 24 has recommended that tests be performed at monthly intervals to assure electron beam energy constancy by verifying the depth for the 80% dose to within +/- 3 mm. Typically, this is accomplished by using a two-depth dose ratio technique. Recently, a new device, the Geske monitor, has been introduced that is designed for verifying energy constancy in a single reading. The monitor consists of nine parallel plate detectors that alternate with 5-mm-thick absorbers made of an aluminum alloy. An evaluation of the clinical usefulness of this monitor for the electron beams available on a Varian Clinac 20 has been undertaken with respect to energy discrimination. Beam energy changes of 3 mm of the 80% dose give rise to measurable output changes ranging from 1.7% for 20-MeV electron beams to 15% for 6-MeV electron beams.

An assessment of a film enhancement system for use in a radiation therapy department

The clinical uses of a radiotherapy film enhancement system are explored. The primary functions of the system are to improve the quality of poorly exposed simulator and portal films, and to perform comparisons between the two films to determine whether patient or block positioning errors are present. Other features include: the production of inexpensive, high quality hardcopy images of simulation films and initial portal films for chart documentation, the capacity to overlay lateral simulation films with sagittal MRI films to aid in field design, and a mode to zoom in on individual CT or MRI images and enlarge them for video display during chart rounds or instructional sessions. This commercially available system is comprised of a microcomputer, frame grabber, CCD camera with zoom lens, and a high-resolution thermal printer. The user-friendly software is menu driven and utilizes both keyboard and track ball to perform its functions. At the heart of the software is a very fast Adaptive Histogram Equalization (AHE) routine, which enhances and improves the readability of most portal films. The system has been evaluated for several disease sites, and its advantages and limitations will be presented.

Dose enhancement in buildup region by lead, aluminum, and lucite absorbers for 15 MVp photon beam

Changes in dose distributions in buildup region resulting from the presence of lead, aluminum, and lucite absorbers above the surface of a polystyrene phantom were evaluated. The surface dose, as a function of the absorber thickness, is presented as well as the influence of the air gap between the lead absorber and the phantom surface. It has been found that the surface dose does not depend on absorber thickness for absorbers thicker than the range of secondary electrons in the absorber material (after corrections for the attenuation of the primary beam in the absorber). Similarly, the depth dose curves in the phantom were elevated only at depths lower than the range of secondary electrons in the phantom. The applicability of the presented data in clinical radiotherapy is discussed.

Boron neutron capture therapy of a murine melanoma

Boron neutron capture therapy has been carried out on BALB/c mice carrying the Harding-Passey melanoma s.c. on the thigh. p-Boronophenylalanine (BPA), a boronated analogue of natural melanin precursors, was used to target boron selectively to melanoma. BPA was administered to the mice either via i.p. injection or p.o. by intubation. 10B concentrations in tumor ranged from 15 to 40 ppm depending on the route and timing of administration. Irradiations with a predominantly thermal neutron beam were performed at the Brookhaven Medical Research Reactor. In the absence of BPA, only transient tumor growth delays were observed at low neutron fluences. At 5 x 10(16) n/m2, 4 of 22 tumors irradiated in the absence of BPA underwent long-term tumor growth control; after p.o. administration of BPA (40 ppm 10B in the tumor), the fraction of tumors controlled increased to 11 of 19. The average dose to the tumor in the latter group was 17.8 Gy, of which 14.8 Gy were due to the 10B neutron capture reaction. The biological effectiveness of the absorbed dose from the neutron capture reaction, at the 50% tumor control level, was found to be twice that of 100 kVp X-rays.

The energy response of agar-alanine phantom dosimeter to gamma radiation

Calculations of the energy response of an electron paramagnetic resonance (EPR) signal induced by gamma radiation in an agar-alanine phantom dosimeter are presented. Theoretically calculated slopes of the EPR signal calibration lines are comparable with those obtained experimentally for low-(50 kVp), medium-(662 keV), and high-(15 MVp) energy photons. The sensitivity of the phantom dosimeter (EPR signal amplitude/Gray) varies less than 2% within the 150- to 20-MeV energy range. For energies above 150 keV, the influence of variations in the size of alanine crystals is negligible.

Continuous three-dimensional radiation dosimetry in tissue-equivalent phantoms using electron paramagnetic resonance in L-alpha-alanine

A new tissue-equivalent phantom material has been developed which also acts as a dosimeter. The new phantom material has a similar elemental composition to that of soft tissue and has a density 1.1 g/cm3. The phantom has an agar-gel base, and contains crystallized L-alpha-alanine which traps radiation-induced free radicals. Samples from the phantom were analyzed by an electron paramagnetic resonance (EPR) spectrometer and the intensity of the EPR signal was related to the absorbed dose. When calibrated, the phantom material acts as a dosimeter, with applications in radiation therapy.

Technical structure of a radiotherapy protocol

Multi-institutional cooperative group trials require conformity to a uniform set of therapeutic guidelines so that all patients entered on the study are treated the same regardless of which participating center enters the case. This can come about only if an unambiguous, clearly defined treatment program is included in the protocol. Examples of confusing protocol guidelines from recent Group studies demonstrate how well-meaning participants can inadvertently deviate from study requirements. The Quality Assurance Review Center has developed an outline for the radiotherapy component of a study which has alleviated this problem considerably.

Quantitative evaluation of a portal film contrast enhancement technique

A study was conducted to evaluate the subjective improvement in portal film image quality resulting from the contact copy contrast enhancement technique which was introduced six years ago. Five observers were asked to identify and orient polyvinyl chloride cylinder images on both original and contrast-enhanced portal films taken with a 10-MeV linear accelerator. Fixed reviewing periods (T) were alloted of 20, 40, and 60 s as well as unlimited viewing time in order to increase the clinical relevance of this comparison. A scoring system and a probability representation were used to compare the original and enhanced films as a function of T. The results show a substantial increase in object detectability for the enhanced films at the short viewing times (T = 20, 40, and 60 s). For longer times (T greater than or equal to 80 s) the object detectability for enhanced and original films is not statistically different.

The variability of clinical thermoluminescent dosimetry systems: a multi-institutional study

Thirty-two radiotherapy centers in the USA and Canada cooperated in a study of the variability of clinical thermoluminescent dosimetry (TLD) systems. The primary purpose of the survey was to ascertain the accuracy of TLD for the determination of in vivo dose measurements. Each participating institution provided two TLD packets for irradiation on a Clinac 4, at a prearranged time. Two batch irradiations were made. Thirty-two TLD packets, one from each institution, were uniformly irradiated to a dose of 22.35 cGy (known by us, but not by the participants). A second group of 32 packets were likewise irradiated to a dose of 179.0 cGy. Participants were told only that their TLD's would be irradiated to doses between 10 and 50 cGy, and 100 to 200 cGy. TLD's were then returned to the institutions of origin for readout, and the doses reported to us for analysis. Calibration factors, readout and annealing procedures, etc., were all established independently by each participant. Although these procedures varied widely between institutions, the mean values of the reported doses were within 5% and 3% of the expected values for the low and high doses, respectively. Standard deviations in the reported doses were 10% and 5%. Also of interest, however, is the finding that 22% (i.e., 14 out of 64) of the dose reportings were in error by more than 10%. The implications of these findings vis à vis radiotherapy are discussed.

A quantitative assessment of portal film contrast as a function of beam energy

Portal film contrast on a specially designed test phantom has been studied as a function of photon beam energy and object-to-film distance. The results provide important insights into the physical processes responsible for image contrast. In particular, theoretical calculations of Compton scatter reactions in the phantom can be used to predict visual film contrast. Good agreement between theory and experiment can be achieved by evaluating the double differential Compton cross sections [d sigma (E,theta)/dE d theta] in the test object without resorting to variable parameters or artificial normalization. These calculations demonstrate the importance of low-energy photons, object-to-film distance, and object size on portal film contrast.

Polyacrylamide-based phantoms as tissue substitute in experimental radiation physics

Polyacrylamide-based tissue-equivalent phantoms simulating cortical bone and muscle are described. The equivalency is based upon similar elemental composition and density, and partial similarity in the morphology of bone. Satisfactory results were obtained when the phantoms were tested at low (20 keV) and high (15 MeV) gamma radiation. Applicability of this phantom material to neutron transport is discussed. The material can be molded and shaped and its composition is easily modified by altering the proportions of the constituents. Trace elements or radionuclides are easily added. Details of the physical and radiation characteristics of the formulated systems are given together with the manufacturing procedures.

Impact of a dosimetry review program on radiotherapy in group trials

The impact of a quality assurance program on protocol compliance has been explored. A sample of 2258 patients, who received radiation therapy on 18 different NCI funded protocols, was selected for this study from the more than 6200 cases reviewed by the Quality Assurance Review Center (QARC) from 1974 to 1983. Analysis of this sample reveals a significant decrease in the protocol non-compliance rate as a function of QA participation time (35% down to 5%). The educational impact of the QA program is demonstrated by the drop in the protocol dose deviation rate from 11.4% (before QARC feedback) to 3.6% (after feedback, p less than .001). The corresponding drop in protocol deviations in treatment volume is from 21.5% to 10.5% (p less than .001). The effect of the "on-treatment" review process is studied; it is demonstrated that this process cuts the rate of major deviations in half. The technical discrepancies in dose are also analyzed and discussed.

Portal film quality: a multiple institutional study

The variation in quality of the several thousand portal films submitted to the Quality Assurance Review Center (QARC) has been substantial. To ascertain the nature and severity of this problem, a detailed study of "whole brain" portal films which were taken at 23 different radiotherapy departments for patients entered on three national leukemia studies was performed. Each film was analyzed in two ways: (a) independent subjective evaluation by four experienced radiotherapists and (b) measurement of objective parameters. Scores from 416 evaluations together with measured parameters were stored in a data base system for easy statistical manipulation. The dependence of perceived film quality on these objective parameters has been correlated and is the subject of this report.

Quality control of radiotherapy in acute lymphocytic leukemia protocol treatment: experience with 610 cases

Quality assurance programs are necessary in multi-institutional cooperative group clinical trials to ensure that possible inter-institutional differences in selection, treatment and evaluation of patients will not erode the statistical assessment of these clinical trials. The Radiotherapy Committee of the Cancer and Leukemia Group B examined the evaluability and appropriateness of treatment of patients entered into two protocols for childhood acute lymphocytic leukemia, 7411 prior to and 7611 after the development of a quality assurance review program. Of the 348 patients entered into 7411, 37% were evaluable and 26% were appropriately treated in 1974 when the protocol opened. This rose to 53 and 35% in the last year of the study. On the other hand, in 7611 with an ongoing quality assurance program, the evaluability rate initially was 63% and rose to 73% and the appropriateness rate rose from 37 to 61%. This change in performance which was statistically significant at the P = 0.001 level is attributed to the impact of the Quality Assurance Review Center correspondence. Improvement in performance occurred almost entirely in the principal centers and not in satellite institutions. This difference in performance was statistically significant at the P = 0.05 level, indicating that adherence to protocol requirements increases with increased participation in studies.

Computer-controlled direct TMR measurement

It is common practice to derive tissue maximum ratios (TMRs) indirectly by calculation from percent depth dose (PDD) data which are more convenient to measure using currently available automated scanners. A system has been developed, however, for the completely automatic direct measurement of TMR, using an ionization chamber which is rigidly supported at the isocenter of a teletherapy machine. The chamber is immersed in a water phantom which is moved up and down by computer control of the motorized treatment couch. Ionization current is sampled by the computer which simultaneously regulates both the radiation field size and chamber depth. This system provides a means of rapidly measuring and processing complete sets of TMR and output factor values for both square and elongated field shapes. The results of such measurements performed on the Clinac 18 accelerator are described in this paper.

A dosimetry review system for cooperative group research

The validity of conclusions drawn from multi-institutional radiotherapy studies is dependent upon the degree to which participating hospitals adhere to study requirements. A major effort undertaken by the Quality Assurance Review Center (QARC) assesses whether or not patient data which are deemed evaluable actually conform to the radiotherapy requirements of the research protocol. This paper presents the methods and results of this effort which has been ongoing for the past five years. The Dosimetry Review System (DRS) is a set of computer programs which make use of verified radiation beam data to evaluate the daily dose, total dose, dose uniformity, and TDF for protocol treatment. These programs can be adapted to facilitate and document the routine chart-checking procedures at any large radiotherapy department. The DRS data base includes radiotherapy parameters of 600 teletherapy units at more than 250 institutions in the United States and abroad. The design of the data base, the computerized review process, and the calculational algorithms are discussed.

Quality assurance programs in clinical trials

Quality assurance programs attempt to assess the uniformity of compliance with a stated study program so that the results from one institution will indeed be comparable to those of all of the other institutions in the group. In the best situation, it should be easy to compare results from one group to those of any other group and any other studies of the same disease, because the basis of selection of the patient population, the treatment of patients, and the endpoints have been uniformly defined throughout. The evaluation of the end results includes a quantitative assessment of the appropriateness of these parameters. Quality assurance programs document the validity of interinstitutional, intergroup, and international studies. They are time-consuming and costly. They can be ulcerogenic. But, in the end, they are the firm basis upon which the statistical analysis can proceed.

Contrast enhancement of high-energy radiotherapy films

An order-of-magnitude improvment in the contrast of high-energy localization and verification films has been achieved through the application of a simple, inexpensive, contrast enhancement technique. The method involves making reversal contact "prints" of the original film onto ordinary X-ray fi-m with equipment commonly available in any radiotherapy department. This results in "gamma multiplication". The theory as well as several applications of this effect are presented.